A decreasing trend by KRW 11 (upper respiratory infections), KRW 14 (otitis media), and KRW 20 (urinary tract infections) was noted between Policy 1 and the Uniform Ceiling Prices for Generics (Policy 2).
← all excerpts
The Effects of Cost Containment and Price Policies on Pharmaceutical Expenditure in South Korea.
1
—
—